Los Angeles, CA | iStent Animation MIGS | Ophthalmology Associates of the Valley

Speaker 1: The emergence of Micro Invasive Glaucoma Surgery, or MIGS procedures, is an exciting new option in glaucoma management. MIGS devices are designed to improve aqueous outflow through the natural physiologic pathways of the eye, and are implanted ab-interno through a micro incision while maintaining the integrity of eye tissues. Today, we are able to safely and effectively reduce IOP with a patent bypass that is designed to create a permanent opening. Introducing iStent from glucose corporation. The first FDA approved Trabecular Micro-Bypass implant. iStent is indicated for use in conjunction with cataract surgery for the reduction of interocular pressure in adult patients with mild to moderate open angle glaucoma currently treated with ocular hypotensive medications. iStent provides a sustainable foundation for achieving target pressures by improving physiologic outflow between the anterior chamber and the conventional outflow system. The iStent Trabecular Micro-Bypass, an exciting new treatment option for patients with mild to moderate open angle glaucoma who are undergoing cataract surgery. The next logical step in comprehensive cataract surgery.